• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替考拉宁用于革兰氏阳性菌感染:微生物学方面

Teicoplanin in gram-positive infection: microbiological aspects.

作者信息

Spencer R C

机构信息

Department of Bacteriology, Royal Hallamshire Hospital, Sheffield, UK.

出版信息

Eur J Haematol Suppl. 1993;54:6-9. doi: 10.1111/j.1600-0609.1993.tb01898.x.

DOI:10.1111/j.1600-0609.1993.tb01898.x
PMID:8365463
Abstract

The widespread use of indwelling catheters and successful antibiotic treatment of Gram-negative infections has led to an increase of Gram-positive infections in severely neutropenic patients; Staphylococcus epidermidis is predominant in these infections. The problems associated with the use of vancomycin in treating such infections can be overcome by the glycopeptide antibiotic teicoplanin. It is as effective as vancomycin, but does not cause "red man" syndrome, is uncommonly nephrotoxic, can be given as a rapid bolus once daily, and routine serum monitoring is not required. Other approaches to reducing catheter-related infections include improved training of personnel in catheter insertion and the development of new materials and methods in cannula production.

摘要

留置导管的广泛使用以及革兰氏阴性菌感染的成功抗生素治疗导致严重中性粒细胞减少患者革兰氏阳性菌感染增加;表皮葡萄球菌在这些感染中占主导地位。糖肽类抗生素替考拉宁可克服使用万古霉素治疗此类感染所带来的问题。它与万古霉素效果相当,但不会引起“红人”综合征,肾毒性罕见,可每日一次快速推注给药,且无需常规血清监测。减少导管相关感染的其他方法包括加强人员在导管插入方面的培训以及开发插管生产的新材料和新方法。

相似文献

1
Teicoplanin in gram-positive infection: microbiological aspects.替考拉宁用于革兰氏阳性菌感染:微生物学方面
Eur J Haematol Suppl. 1993;54:6-9. doi: 10.1111/j.1600-0609.1993.tb01898.x.
2
Teicoplanin in combination: role in the management of the febrile neutropenic patient.
Eur J Haematol Suppl. 1993;54:25-8. doi: 10.1111/j.1600-0609.1993.tb01902.x.
3
A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies.
Eur J Haematol Suppl. 1993;54:10-3. doi: 10.1111/j.1600-0609.1993.tb01899.x.
4
Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.替考拉宁与万古霉素用于发热性中性粒细胞减少症患者的经验性治疗比较
Eur J Haematol Suppl. 1993;54:18-24. doi: 10.1111/j.1600-0609.1993.tb01901.x.
5
"In-situ" Teicoplanin for central venous catheter infection.
Ir J Med Sci. 1995 Apr-Jun;164(2):125-7. doi: 10.1007/BF02973277.
6
Use of vancomycin in central venous catheter-related infections.万古霉素在中心静脉导管相关感染中的应用。
Bone Marrow Transplant. 1996 Feb;17(2):299.
7
Teicoplanin in home therapy of the terminally ill child.
Eur J Haematol Suppl. 1993;54:14-7. doi: 10.1111/j.1600-0609.1993.tb01900.x.
8
Use of teicoplanin for Hickman catheter associated staphylococcal infection in immunosuppressed patients.
J Hosp Infect. 1987 Jul;10(1):77-82. doi: 10.1016/0195-6701(87)90036-3.
9
Polyclonal Staphylococcus epidermidis intravascular catheter-related infections.多克隆性表皮葡萄球菌血管内导管相关感染
Clin Microbiol Infect. 2001 Jul;7(7):388-91. doi: 10.1046/j.1198-743x.2001.00272.x.
10
Central venous catheter infections treated with teicoplanin.
Eur J Haematol Suppl. 1998;62:15-7. doi: 10.1111/j.1600-0609.1997.tb01704.x.

引用本文的文献

1
Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.替考拉宁:对其用于治疗革兰氏阳性菌感染的药物经济学评价
Pharmacoeconomics. 1995 Apr;7(4):357-74. doi: 10.2165/00019053-199507040-00009.
2
Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.替考拉宁:对其抗菌活性、药代动力学特性及治疗效果的重新评估
Drugs. 1994 May;47(5):823-54. doi: 10.2165/00003495-199447050-00008.